Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.02 | N/A |
| PEG Ratio (TTM) | 0.00 | N/A |
| P/S Ratio (TTM) | 0.20 | N/A |
| P/B Ratio (TTM) | 0.08 | N/A |
| P/FCF Ratio (TTM) | -0.26 | N/A |
| Price to 5YR AVG Earnings Ratio | -0.02 | N/A |
| Price to 5YR AVG FCF Ratio | -0.20 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -157.66% | N/A |
| ROE (TTM) | -205.68% | N/A |
| Net Profit Margin (TTM) | -561.80% | N/A |
| ROIC 5YR AVG | -54.42% | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -2,175.71% | -99.24% | -84.82% |
| Revenue | -16.42% | 317.97% | 212.30% |
| Net Income | -4,039.38% | -302.46% | -332.78% |
| Cash Flow | -31.88% | -256.76% | -177.35% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.81 | N/A |
| Quick Ratio (TTM) | 0.57 | N/A |
| D/E Ratio (TTM) | 0.80 | N/A |
| Interest Coverage (TTM) | -53.19 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -0.01 | N/A |
| Shares Outstanding Growth 5YR AVG | 105.06% | N/A |